Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Exploration of gastric neuroendocrine carcinoma (GNEC) specific signaling pathways involved in chemoresistance via transcriptome and in vitro analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Carcinoid tumors of the stomach
10.1016/s0960-7404(03)00034-3 · 2003 · External reference
One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
10.1200/jco.2007.15.4377 · 2008 · External reference
Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis
10.1007/s00535-014-0934-2 · 2015 · External reference
10.18632/oncotarget.9805
10.18632/oncotarget.9805 · External reference
10.1530/erc-15-0075
10.1530/erc-15-0075 · External reference
Activity of a three-drug combination including cisplatin (CLOVER regimen) for poorly differentiated neuroendocrine carcinoma
2014 · External reference
Different long-term oncologic outcomes after radical surgical resection for neuroendocrine carcinoma and adenocarcinoma of the stomach
10.18632/oncotarget.15488 · 2017 · External reference
10.5858/arpa.2015-0102-rs
10.5858/arpa.2015-0102-rs · External reference
10.1093/nar/gkw871
10.1093/nar/gkw871 · External reference
The melanocortin signaling cAMP axis accelerates repair and reduces mutagenesis of platinum-induced DNA damage
10.1038/s41598-017-12056-5 · 2017 · External reference
Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells
10.1016/j.ejphar.2016.11.043 · 2017 · External reference
Current opinions on chemoresistance: an overview
10.6026/97320630014080 · 2018 · External reference
10.1016/j.dnarep.2018.03.004
10.1016/j.dnarep.2018.03.004 · External reference
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
10.1093/annonc/mdh216 · 2004 · External reference
10.3748/wjg.v23.i11.2012
10.3748/wjg.v23.i11.2012 · External reference
CDK5 suppresses the metastasis of gastric cancer cells by interacting with and regulating PP2A
2019 · External reference
A knockin mouse model for human ATP4a R703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategies
10.1242/dmm.025890 · 2016 · External reference
Gene signatures of drug resistance predict patient survival in colorectal cancer
10.1038/tpj.2014.45 · 2015 · External reference
Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population
10.1016/j.seizure.2015.05.013 · 2015 · External reference
10.1093/nar/gkx247
10.1093/nar/gkx247 · External reference
10.18632/oncotarget.10337
10.18632/oncotarget.10337 · External reference
10.2337/db19-0117
10.2337/db19-0117 · External reference
10.1016/j.celrep.2016.06.081
10.1016/j.celrep.2016.06.081 · External reference
10.1111/cas.12628
10.1111/cas.12628 · External reference
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer
10.1158/1078-0432.ccr-07-4557 · 2008 · External reference
Two novel determinants of etoposide resistance in small cell lung cancer
10.1158/0008-5472.can-11-0080 · 2011 · External reference
10.18632/oncotarget.600
10.18632/oncotarget.600 · External reference
10.1007/s00280-013-2108-y
10.1007/s00280-013-2108-y · External reference
HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
10.1186/s13048-016-0240-0 · 2016 · External reference
miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC)
10.1039/c6mb00576d · 2016 · External reference
